To determine whether its binding to p53 could occur in cancer cells, we used isogenic human colon cancer cell lines HCT-116p53+/+ (wild-type p53) and HCT-116p53−/− (p53-null background). This evidence concerns the gene TP53 and colonic neoplasm.